Viridian Therapeutics Inc.

10/14/2021 | Press release | Distributed by Public on 10/14/2021 06:07

Viridian Therapeutics Submits Investigational New Drug Application for VRDN-001, an IGF-1R antibody for the treatment of Thyroid Eye Disease, to the U.S. Food and Drug[...]